This research seeks to define the biochemistry and cell biology of endothelial cell basement membrane degradation by malignant cells. Basement membranes elaborated by cultured bovine endothelial cells and labeled with radioactive precursors in specific components will be prepared using novel techniques developed in this laboratory. The subendothelial matrix has been characterized biochemically by sequential enzyme hydrolysis, gel electrophoresis, electron microscopy, and immunofluorescence. The degradation of basement membrane by human tumor cell lines has been investigated in detail and the role of tumor proteases, especially the tumor cell plasminogen activator, defined. Human fibrosarcoma cells are capable of the complete degradation of the subendothelial matrix after removal of the endothelial cells. We also have found that living endothelial cells secrete a factor which inhibits the degradation of the membrane by tumor cells. This regulation of tumor cell aggressive behavior by a normal cell type could have major importance in the metastatic process and we are characterizing it in more detail. Subendothelial matrices also are being used for the routine culture of primary explants of human pediatric tumors. The subendothelial matrix also stimulates the differentiation of normal cells cultured upon it and we are determining which factors within the subendothelium play important roles in this stimulation. The subendothelial matrix, therefore, can be degraded by invasive cells and can modulate the differentiation of certain other cell types, and endothelial cells themselves inhibit protease production by malignant cells. All of these properties may play key roles in the establishment of secondary tumors during metastasis. (A)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA040422-01
Application #
3180319
Study Section
Pathology B Study Section (PTHB)
Project Start
1985-01-01
Project End
1987-12-31
Budget Start
1985-01-01
Budget End
1985-12-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Weiss, R E; Liu, B C; Ahlering, T et al. (1990) Mechanisms of human bladder tumor invasion: role of protease cathepsin B. J Urol 144:798-804
Allen, L E; Dubeau, L; Alvarez, O et al. (1990) Rapid degradation of extracellular matrix proteins by normal human uroepithelial cells. Cancer Res 50:1897-904
Pritchett, T R; Wang, J K; Jones, P A (1989) Mesenchymal-epithelial interactions between normal and transformed human bladder cells. Cancer Res 49:2750-4
Dubeau, L; Jones, P A; Rideout 3rd, W M et al. (1988) Differential regulation of plasminogen activators by epidermal growth factor in normal and neoplastic human urothelium. Cancer Res 48:5552-6
Dubeau, L; Weinberg, K; Jones, P A et al. (1988) Studies on immunoglobulin gene rearrangement in formalin-fixed, paraffin-embedded pathology specimens. Am J Pathol 130:588-94
Dubeau, L; Jones, P A (1987) Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium. Cancer Res 47:2107-12
Ahlering, T E; Dubeau, L; Jones, P A (1987) A new in vivo model to study invasion and metastasis of human bladder carcinoma. Cancer Res 47:6660-5
Chandler, L A; Ghazi, H; Jones, P A et al. (1987) Allele-specific methylation of the human c-Ha-ras-1 gene. Cell 50:711-7
Dubeau, L; Chandler, L A; Gralow, J R et al. (1986) Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res 46:2964-9
Chandler, L A; DeClerck, Y A; Bogenmann, E et al. (1986) Patterns of DNA methylation and gene expression in human tumor cell lines. Cancer Res 46:2944-9

Showing the most recent 10 out of 11 publications